ATC
XPH icon

Advantage Trust Company’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Advantage Trust Company’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,250
Closed -$156K – 190
2025
Q3 		$156K Hold
3,250
– – 0.07% 67
2025
Q2 		$132K Buy
3,250
+3,050
+1,525% +$123K 0.07% 72
2025
Q1 		$8.76K Hold
200
– – 0.01% 138
2024
Q4 		$8.6K Hold
200
– – 0.01% 154
2024
Q3 		$8.87K Sell
200
-3,250
-94% -$139K 0.01% 144
2024
Q2 		$137K Sell
3,450
-720
-17% -$29.2K 0.1% 54
2024
Q1 		$180K Hold
4,170
– – 0.13% 45
2023
Q4 		$174K Buy
+4,170
New +$158K 0.14% 45

Other funds holding XPH

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $18.1B AUM 15% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return